Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at EXP's multiple
$2.4339.1% below market
0.94 ZNTL revenue / share×2.58x EXP P/S=$2.43
Market $3.99Implied $2.43
EXP · current priceP/S 2.58x
$194.48Latest market snapshot
Implied fair value · at ZNTL's multiple
$319.2164.1% above market
75.26 EXP revenue / share×4.24x ZNTL P/S=$319.21
Market $194.48Implied $319.21